Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, ...

BELLEVILLE - Tera and Fredrick Mothersell are organizing a fundraiser to support their 12-year-old son, Richard, as he battles bone cancer for the second ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

Immunologists from UNIGE have discovered the previously unsuspected anti-tumor potential of CD4 T lymphocytes. An important ...

July marks National Sarcoma Awareness Month, a crucial time to spotlight a rare but serious group of cancers that can form in ...

As a pet parent, you’re probably accustomed to taking your cat to the veterinarian for their vaccines. And while it may seem ...

FDA grants fast track designation to CLD-201, an innovative therapy for soft tissue sarcoma, enhancing its development and ...

A Georgetown pediatrician who dedicated nearly four decades to caring for Kentucky's children received a bittersweet honor as ...

A new clinic at The University of New Mexico Comprehensive Cancer Center is working to treat cancers on the outside and ...

The firm will retain rights to its preclinical assets including two T-cell receptor T-cell therapies and its allogenic program.

A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.

The new owner of Adaptimmune's T-cell treatment for a rare form of cancer is expected to offer jobs to most of the 160 people ...